UBS Group’s Artelo Biosciences, Inc. Warrant ARTLW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,697
| Closed | -$75 | – | 10344 |
|
|
2024
Q1 | $75 | Buy |
+4,697
| New | +$100 | ﹤0.01% | 8881 |
|
|
2023
Q4 | – | Sell |
-100
| Closed | -$4 | – | 10209 |
|
|
2023
Q3 | $4 | Buy |
+100
| New | +$5 | ﹤0.01% | 9312 |
|
|
2023
Q2 | – | Sell |
-687
| Closed | -$48 | – | 9970 |
|
|
2023
Q1 | $48 | Sell |
687
-7,536
| -92% | -$469 | ﹤0.01% | 9346 |
|
|
2022
Q4 | $329 | Buy |
+8,223
| New | +$685 | ﹤0.01% | 10243 |
|
|
2022
Q3 | – | Sell |
-289
| Closed | – | – | 11186 |
|
|
2022
Q2 | $0 | Sell |
289
-1
| -0.3% | – | ﹤0.01% | 11193 |
|
|
2022
Q1 | $0 | Buy |
290
+90
| +45% | +$14 | ﹤0.01% | 11120 |
|
|
2021
Q4 | $0 | Sell |
200
-4,177
| -95% | -$901 | ﹤0.01% | 10889 |
|
|
2021
Q3 | $1K | Sell |
4,377
-190
| -4% | -$55 | ﹤0.01% | 9288 |
|
|
2021
Q2 | $2K | Buy |
+4,567
| New | +$1.46K | ﹤0.01% | 9006 |
|
UBS Group's ARTLW Position: Q2 2024 in Review
UBS Group sold out of Artelo Biosciences, Inc. Warrant (ARTLW) in Q2 2024, closing a stake of 4,697 shares — an estimated $75 sold.
UBS Group first reported a position in ARTLW in Q2 2021 and held it in 9 quarters. The position peaked at $2K in Q2 2021. 0 funds tracked by Wall St. Rank hold ARTLW as of Q2 2024.
- UBS Group reported no remaining Artelo Biosciences, Inc. Warrant position as of Q2 2024 after selling out during the quarter.
- UBS Group sold 4,697 Artelo Biosciences, Inc. Warrant shares in Q2 2024, an estimated $75.
- UBS Group first reported a position in Artelo Biosciences, Inc. Warrant in Q2 2021 and held it in 9 quarters.
- UBS Group's Artelo Biosciences, Inc. Warrant position peaked at $2K in Q2 2021.
- 0 funds tracked by Wall St. Rank held Artelo Biosciences, Inc. Warrant as of Q2 2024.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.